Manufacture

Researchers conduct small phase I study on placenta-derived stem cell therapy to treat a serious form of multiple sclerosis

The development of CAR T-cell technology is a defining moment in the history of biomedicine – one of the all-time amazing transformative breakthroughs

The industry has spent decades optimizing distribution strategies to meet faster timelines. Now, it’s time to think about sustainability.

We ask an analyst how pharma companies can weather the volatile economic environment and the Trump administration’s tariffs.

Helping biopharma manufacturers to accelerate their time to market, with sustainable practices; here’s how Ecolab is making a difference

Our latest news roundup reports on research targeting solid tumors, a personalized CRISPR gene therapy for a young infant, a comedy show to raise mone

A review article examines the evolving strategies and safety outcomes with allogeneic CAR T cell therapy.

Biopharma has been using lyophilization to stabilize injectables for more than 80 years, but the technique is capable of so much more.

Biotech company Ethris explains the benefits and challenges of developing spray dried RNA vaccines.

Carl June and UPenn researchers develop next generation CAR T cell therapy and demonstrate promising results in phase I trial.